Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis
- 1 February 1996
- journal article
- expedited publication
- Published by Wiley in Annals of Neurology
- Vol. 39 (2), 147-157
- https://doi.org/10.1002/ana.410390203
Abstract
Familial amyotrophic lateral sclerosis (FALS) has been linked in some families to dominant mutations of the SOD1 gene encoding Cu,Zn superoxide dismutase (Cu,Zn SOD). We have used a transgenic model of FALS based on expression of mutant human Cu,Zn SOD to explore the etiology and therapy of the genetic disease. Expression of mutant, but not wild-type, human Cu,Zn SOD in mice places the brain and spinal cord under oxidative stress. This causes depletion of vitamin E, rather than the typical age-dependent increase in vitamin E content as occurs in nontransgenic mice and in mice expressing wild-type human Cu,Zn SOD. Dietary supplementation with vitamin E delays onset of clinical disease and slows progression in the transgenic model but does not prolong survival. In contrast, two putative inhibitors of the glutamatergic system, riluzole and gabapentin, prolong survival. However, riluzole did not delay disease onset. Thus, there was clear separation of effects on onset, progression, and survival by the three therapeutics tested. This suggests the hypothesis that oxidative damage produced by the expression of mutant Cu,Zn SOD causes slow or weak excitotoxicity that can be inhibited in part by altering glutamate release or biosynthesis presynaptically.Keywords
This publication has 49 references indexed in Scilit:
- Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS)Brain Research, 1995
- Antioxidants and physical performanceCritical Reviews in Food Science and Nutrition, 1995
- Mutant Mice, Cu,Zn Superoxide Dismutase, and Motor Neuron DegenerationScience, 1994
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia.Stroke, 1994
- Age‐Related Regional Changes in Hydroxyl Radical Stress and Antioxidants in Gerbil BrainJournal of Neurochemistry, 1993
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993
- Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemiaNeuroscience Letters, 1992
- Effects of tirilazad mesylate on postischemic brain lipid peroxidation and recovery of extracellular calcium in gerbils.Stroke, 1991
- Down's syndrome: morphological remodelling and increased complexity in the neuromuscular junction of transgenic CuZn-superoxide dismutase miceJournal of Neurocytology, 1991